Please login to the form below

Not currently logged in
Email:
Password:

real-world evidence

This page shows the latest real-world evidence news and features for those working in and with pharma, biotech and healthcare.

NICE plans to widen the net for data it uses in guidance

NICE plans to widen the net for data it uses in guidance

Plans to include electronic health records and real-world evidence. UK cost-effectiveness body NICE has said it intends to use a broader range of data and analytics in the formulation ... Extending the range of data to include patient records, real-world

Latest news

  • NICE knocks back J&J’s depression nasal spray Spravato NICE knocks back J&J’s depression nasal spray Spravato

    Meindert Boysen, director of the centre for health technology evaluation at NICE said: "There is a lack of evidence comparing esketamine with all relevant comparators, and the committee concluded that the ... Hitting back at the critics, director of

  • The digital shift in pharma marketing The digital shift in pharma marketing

    While the efficacy and safety profile of drugs remained the most sought-after information for prescriptions, there was an unprecedented increase in requests for real-world evidence. ... These companies scored poorly on tools’ deployment for social

  • Immuno-oncology, personalised medicine continues to drive pharma sector Immuno-oncology, personalised medicine continues to drive pharma sector

    Coming in after I-O and personalised medicines as the top most impactful trends was the growing role of  real-world evidence and a rise in the use of  electronic health ... England’s world-leading  100, 000 Genomes Project.

  • Blind man's buff Blind man's buff

    Real-world evidence is beginning to be used to demonstrate real-world outcomes and value. ... The IQWIG evidence tells us that our industry is wasteful of its innovative resources.

  • Who's calling the shots in European healthcare? Who's calling the shots in European healthcare?

    greater real-world evidence (RWE)? ... Maintain and develop Europe’s world-class IP system. Advance Europe’s Smart trade agenda.

More from news
Approximately 12 fully matching, plus 83 partially matching documents found.

Latest Intelligence

  • The long and winding road to asthma breakthroughs The long and winding road to asthma breakthroughs

    The company’s severe eosinophilic asthma biologic Nucala (mepoluzimab), an Interleukin-5 inhibitor, has been buoyed by a real-world evidence study – presented at the recent European Respiratory Society’s International

  • Patient journey mapping: exploring the clinical and the emotional journey Patient journey mapping: exploring the clinical and the emotional journey

    As a starting point, understanding how patients proceed through the healthcare delivery system, using validated real-world data is essential. ... professional. In addition to mapping clinical patient pathways, the use of HES data can support the

  • Evolution or revolution: the latest review of NICE methods Evolution or revolution: the latest review of NICE methods

    on Access to Medicines and Medical Devices evidence sessions on the NICE methods review inquiry. ... Part of exploring uncertainty and how to reduce it will include data analytics and real-world evidence.

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    She added: “Being able to show that real-world benefit, in a specific population in a specific market, makes a huge difference in those negotiations.”. ... This is the first large real-world evidence study of its kind, evaluating the risk of

  • The evolution of marketing – the Amgen way The evolution of marketing – the Amgen way

    Commercial functions have been evolving and, beyond traditional marketing, teams are required to develop various acumens, such as access, real-world evidence generation, beyond the molecule services and value-based partnerships. ... world. I learnt what

More from intelligence
Approximately 9 fully matching, plus 61 partially matching documents found.

Latest appointments

  • Remi Gauchoux joins Carenity Remi Gauchoux joins Carenity

    Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis.

  • Dr Ameet Nathwani moves from Novartis to Sanofi Dr Ameet Nathwani moves from Novartis to Sanofi

    Oliver Brandicourt, Sanofi's chief executive officer, said: “Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products

  • EMA's Dr Stella Blackburn joins Quintiles EMA's Dr Stella Blackburn joins Quintiles

    Cynthia Verst, president, real world and late phase research at Quintiles, said: “Stella's experience developing innovative risk management solutions is a tremendous addition to our team. ... She said: “Together with my colleagues at Quintiles, I aim

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 7 fully matching, plus 34 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics